Stimulation with TLR2 and 4 ligands, resulted in greater production of pro-inflammatory mediators, potentially due to obesity-induced changes in TLR activation in myeloid cells (Ahmad et al., 2012). The gene discussed is TLR2; the disease is obesity due to melanocortin 4 receptor deficiency.